BDA-366 10mg 10mg | Purity Not Available
Adooq Bioscience
BDA-366 selectively inhibits BCL2, converting it to a cell death inducer.
More Information Supplier PageBDA-366 selectively inhibits BCL2, converting it to a cell death inducer.
More Information Supplier PageRPC1063 is a selective sphingosine 1 phosphate receptor modulators and methods which may be useful in the treatment of S1P1-?associated diseases.
More Information Supplier PageRPC1063 is a selective sphingosine 1 phosphate receptor modulators and methods which may be useful in the treatment of S1P1-?associated diseases.
More Information Supplier PageRPC1063 is a selective sphingosine 1 phosphate receptor modulators and methods which may be useful in the treatment of S1P1-?associated diseases.
More Information Supplier PageGSK2190915 is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.
More Information Supplier PageGSK2190915 is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.
More Information Supplier PageGSK2190915 is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.
More Information Supplier Page